|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2020
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/12075
Full metadata record
DC Field | Value | Language |
dc.contributor.author | Golban, Mariana | - |
dc.date.accessioned | 2020-10-09T12:58:47Z | - |
dc.date.available | 2020-10-09T12:58:47Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | GOLBAN, Mariana. Charge syndrome. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 39-40. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12075 | - |
dc.description | Department of Neurology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
dc.description.abstract | Background. Introduction. In this descriptive study the clinical and neurological issues related
to CHARGE syndrome (C – coloboma, cranial nerves; H – heart defects; A – atresia of the
choanae; R – retardation in growth, mental development, G – genital abnormalities, E – ear
malformation / hearing loss) were assessed. The study presents the clinical examination of one
case with typical form of pathology, along with the identification of diagnosis and treatment
particularities. Aim of study. Being a relatively rarely encountered disease, it requires a
separate attitude from both patients and medical staff. The aim of the study is the identification
of typical existing forms of the disease, in order to determine the principles and methods of
diagnosis and treatment.
Case report. Materials and methods. A 19 years old boy was admitted to the Institute of
Neurology and Neurosurgery, Chisinau, Republic of Moldova in February, 2020 being
evaluated according to clinical methods (investigation, anthropometry) and laboratory tests.
Ressults. The patient’s complaints were: hearing impairment, memory loss, pain in thoracic
and lumbar spine, headache, asthenia, myalgia. Neurological examination: hyposmia; the
presence of hearing loss in left ear, and hypoacusis in the right ear; unsteady Romberg’s
position; diffuse hypotonia. Somatic examination: BMI = 14,7 kg/m2 (hyponutrition), regular
pulse, BP = 120/90 mmHg. Patient presents major criteria: atresia of choane, cranial nerve
dysfunction – I, VIII, IX, and minor criteria: rhomboencephalic dysfunction including sensorial
deafness, hypothalamo-hypophyseal dysfunction (gonadotropin or growth hormone
deficiency) - genital hypoplasia and growth deficiency, characteristic facial features,
intellectual disability, feeding difficulties, skeletal anomalies – thoracic and lumbar scoliosis
grade 2 with rib block T8-T10. Atypical signs: immunodeficiency, gastroesophageal reflux,
sleepiness, vestibular abnormalities. Prior to establishing the final diagnosis, the differential
diagnosis was: Rubinstein-Taybi syndrome and Oppenheim amyotonia. The CHARGE
syndrome is an autosomal dominant genetic condition caused by a mutation in the CHD7 gene.
The patient has 2 sisters, 24 and 21 years old, who are also diagnosed with CHARGE
syndrome. They both are pregnant, and the risk of passing on the syndrome to their offsprings
is very high. Early appropriate investigations of the syndrome facilitate a correct diagnosis and
proper management. Given the number of affected systems in CHARGE syndrome, we believe
that a multidisciplinary clinical model is beneficial in the management of these children: the
general paediatrician, genetic diagnosis, otolaryngologist, ophthalmologist, cardiologist.
Conclusions. The patient manifests a typical phenotype of CHARGE syndrome according to
the Verloes’s criteria. The diagnosis is usually made on clinical grounds. It requires a genetic
test to confirm the CDH7 mutation in order to identify the individual’s and their offsprings’
risk and to initiate an early targeted therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | charge syndrome | en_US |
dc.subject | criteria | en_US |
dc.subject | clinical features | en_US |
dc.subject | genetic testing | en_US |
dc.title | Charge syndrome | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2020
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|